Cost-effectiveness analysis of anastrozole versus tamoxifen in adjuvant therapy for early-stage breast cancer - a health-economic analysis based on the 100-month analysis of the ATAC trial and the German health system.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples